Superovulation and Intrauterine Insemination in Cases of Treated Mild Pelvic Disease

Singh M, M Singh, Mamta Singh, Goldberg J, J Goldberg, Jeffrey M. Goldberg, T. Falcone, Falcone T, Nelson D, David R. Nelson, D Nelson, E Pasqualotto, Pasqualotto E, Eleonora Bedin Pasqualotto, M Attaran, Attaran M, Marjan Attaran, Ashok Agarwal, Agarwal A, A Agarwal
Journal of assisted reproduction and genetics · 2001 · vol. 18(1) , pp. 26–29 · doi:10.1023/a:1026446612485 · PMID:11292992 · PMC3455810 · W1849746015
article OA: bronze CC0 ⤵ 7 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

Superovulation and intrauterine insemination resulted in significantly lower monthly fecundity and live birth rates for women with treated mild endometriosis compared to idiopathic infertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This retrospective study examined 118 women (300 SO/IUI cycles) with laparoscopically treated minimal/mild endometriosis, and 28 women (67 cycles) with minimal/mild distal tubal disease or adnexal adhesions, compared with 111 couples (265 cycles) with idiopathic infertility undergoing superovulation with intrauterine insemination. The endometriosis group had significantly lower monthly fecundity rate (6.8%) and live birth rate (6%) than the idiopathic group (13.5% and 12.1%), while the minimal/mild tubal/adnexal group (10.9% MFR, 7.5% LBR) did not differ significantly from the other groups. The authors conclude that SO/IUI yields higher outcomes in idiopathic infertility, though it remains a reasonable option for both treated mild/minimal endometriosis and mild/minimal tubal/adnexal disease before IVF-ET, with the key limitation being the retrospective design. This paper is centrally about endometriosis — it evaluates SO/IUI outcomes specifically in women with laparoscopically treated minimal/mild endometriosis compared with idiopathic infertility and other mild pelvic disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PurposeOur purpose was to examine the effect of treated mild pelvic disease on the outcome of superovulation with intrauterine insemination (SO/IUI).MethodsThree hundred cycles of SO/IUI were retrospectively reviewed for 118 women with laparoscopically treated minimal/mild endometriosis and 67 cycles for 28 women with minimal/mild distal tubal disease/adnexal adhesions and compared with 265 cycles in 111 couples with idiopathic infertility.ResultsThe monthly fecundity rate (MFR) of 6.8% and live birth rate (LBR) of 6% in the endometriosis group were significantly lower (P = 0.002) than those in the idiopathic infertility group (MFR = 13.5%, LBR = 12.1%). The 10.9% MFR and 7.5% LBR in the minimal/mild tubal/adnexal disease were not significantly different from those in the other two groups.ConclusionsMFR and LBR were higher after SO/IUI in idiopathic infertility compared to those for treated mild/minimal endometriosis or mild/minimal tubal/adnexal adhesions. However, SO/IUI still remains a reasonable option for both these groups prior to IVF-ET.
Full text 4,683 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose: Our purpose was to examine the effect of treated mild pelvic disease on the outcome of superovulation with intrauterine insemination (SO/IUI).

Methods

Three hundred cycles of SO/IUI were retrospectively reviewed for 118 women with laparoscopically treated minimal/mild endometriosis and 67 cycles for 28 women with minimal/mild distal tubal disease/adnexal adhesions and compared with 265 cycles in 111 couples with idiopathic infertility.

Results

The monthly fecundity rate (MFR) of 6.8% and live birth rate (LBR) of 6% in the endometriosis group were significantly lower (P = 0.002) than those in the idiopathic infertility group (MFR = 13.5%, LBR = 12.1%). The 10.9% MFR and 7.5% LBR in the minimal/mild tubal/adnexal disease were not significantly different from those in the other two groups.

Conclusions

MFR and LBR were higher after SO/IUI in idiopathic infertility compared to those for treated mild/minimal endometriosis or mild/minimal tubal/adnexal adhesions. However, SO/IUI still remains a reasonable option for both these groups prior to IVF-ET. Similar content being viewed by others

References

Collins JA, Burrows EA, Willan AR: The prognosis for live birth among untreated infertile couples. Fertil Steril 1995;64:22-28 Tummon I, Asher L, Martin J, Tulandi T: Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 1997;68:8-12 Fedele L, Bianchi S, Marchini M, Villa L, Brioschi D, Parazzini F: Superovulation with human menopausal gonadotrophins in the treatment of infertility associated with minimal or mild endometriosis: A controlled randomized study. Fertil Steril 1992;58:28-31 Marcoux S, Maheux R, Sylvie Berube, Canadian Collaborative Group on Endometriosis: Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997;337:217-222 Hendin B, Falcone T, Hallak J, Nelson D, Vemullapalli S, Goldberg J, Thomas A, Agarwal A: The effect of patient and semen characteristics on live birth rates following intrauterine insemination: A retrospective study. J Assist Reprod Genet 2000;17:245-252 American Fertility Society: Revised classification of endometriosis. Fertil Steril 1985;43:351-352 American Fertility Society: The American Fertility Society classification of adnexal pregnancies, to tubal ligation, adhesions, distal tubal occlusion, tubal occlusion secondary tubal Mullerian anomalies and intrauterine adhesions. Fertil Steril 1988;49:944-955 Nulsen JC, Walsh S, Dumez S, Metzer D: A Randomized and Longitudinal study of human menopausal gonadotrophin with intrauterine insemination in the treatment of infertility. Obstet Gynecol 1993;82:780-786 Dodson WC, Haney AF: Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 1991;55:457-465 Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Joseph A, Mastroianni LJ, Buster JE, Nakajima ST, Vogel DL, Canfield RE: Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999;340:177-183 Agarwell SK, Buyalos RP: Clomiphene citrate with intrauterine insemination: Is it effective therapy in women above the age of 35 years? Fertil Steril 1996;65:759-763 Corsan G, Trias A, Trout S, Kemmann E: Ovulation induction combined with intrauterine insemination in women of 40 years of age and older: Is it worthwhile? Hum Reprod 1996; 11:1109-1112 Lenton EA, Weston GA, Cooke ID: Long-term follow-up of the apparently normal couple with a complaint of infertility. Fertil Steril 1977;28:913-919 Matson PL, Yovich JL: The treatment of infertility associated with endometriosis by in vitro fertilization. Fertil Steril 1986;46:432-434 Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J: Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-18 Peterson CM, Hatasaka HH, Jones KP, Poulson AM, Carrell DT, Urry RL: Ovulation induction with gonadotrophins and intrauterine insemination compared with in vitro fertilization and no therapy: A prospective, nonrandomized, cohort study and metaanalysis. Fertil Steril 1994;62:535-544 Author information Authors and Affiliations Rights and permissions About this article Cite this article Singh, M., Goldberg, J., Falcone, T. et al. Superovulation and Intrauterine Insemination in Cases of Treated Mild Pelvic Disease. J Assist Reprod Genet 18, 26–29 (2001). https://doi.org/10.1023/A:1026446612485 Issue date: DOI: https://doi.org/10.1023/A:1026446612485

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adnexal Diseases Endometriosis Insemination, Artificial, Homologous Superovulation Adnexal Diseases Adnexal Diseases Adnexal Diseases Adult Endometriosis Endometriosis Endometriosis Female Humans Insemination, Artificial, Homologous Logistic Models Male Pregnancy Pregnancy Outcome Retrospective Studies Superovulation

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Cited by (7)

Source provenance

europepmc
last seen: 2026-08-02T06:10:09.037253+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:24.901228+00:00
License: CC0 · commercial use OK